Arne Kristian Skulberg
Background and activities
Post doctoral fellow at ISB, researching naloxone nasal spray. National Coordinating Investigator NINA-1 trial. Consultant Anaesthesiologist Oslo University Hospital, Air Ambulance Department.
Post doctoral fellowship supported by The Norwegian Air Ambulance Foundation and the Central Norway Regional Health Authority.
Scientific, academic and artistic work
A selection of recent journal publications, artistic productions, books, including book and report excerpts. See all publications in the database
Journal publications
- (2022) Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial. Addiction.
- (2021) REBOARREST, resuscitative endovascular balloon occlusion of the aorta in non-traumatic out-of-hospital cardiac arrest: a study protocol for a randomised, parallel group, clinical multicentre trial. Trials. vol. 22 (1).
- (2021) The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers. European Journal of Clinical Pharmacology.
- (2020) NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use. BMJ Open. vol. 10:e041556 (11).
- (2020) Prehospital naloxone administration – what influences choice of dose and route of administration?. BMC Emergency Medicine. vol. 20.
- (2019) Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose—a randomized controlled trial. Addiction. vol. 114 (5).
- (2019) Naloksonnesespray – biotilgjengelighet og opptaksmønster i en fase 1-studie. Tidsskrift for Den norske legeforening. vol. 139 (13).
- (2018) Ambulance-attended opioid overdoses: An examination into overdose locations and the role of a safe injection facility. Substance Abuse.
- (2018) Pharmacokinetics and -dynamics of intramuscular and intranasal naloxone: an explorative study in healthy volunteers. European Journal of Clinical Pharmacology. vol. 74 (7).
- (2018) Pharmacodynamics and arteriovenous difference of intravenous naloxone in healthy volunteers exposed to remifentanil. European Journal of Clinical Pharmacology. vol. 74 (12).
- (2017) Opioid education programs and nasal naloxone rescue kits in Europe. Toxicology Letters. vol. 280.
- (2017) Pharmacokinetics of a new, nasal formulation of naloxone. European Journal of Clinical Pharmacology. vol. 73 (5).
- (2015) Biotilgjenglighet og effekt av nalokson som nesespray sammenliknet med intramuskulær injeksjon. NAForum. vol. 28 (3).
- (2014) Biotilgjenglighet av nalokson som nesespray- grunnlaget for fremtidig prehospital bruk. NAForum. vol. 27 (3).
Report/dissertation
- (2019) Characteristics of Opioid Overdoses and Intranasal Pharmacology of Naloxone. 2019. ISBN 978-82-326-3770-6.